SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-247446
Filing Date
2023-09-29
Accepted
2023-09-29 16:28:35
Documents
16
Period of Report
2023-09-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d490226d8k.htm   iXBRL 8-K 44187
2 EX-4.1 d490226dex41.htm EX-4.1 1023184
3 EX-10.1 d490226dex101.htm EX-10.1 1690006
4 EX-99.1 d490226dex991.htm EX-99.1 8248
8 GRAPHIC g490226page7.jpg GRAPHIC 2954
  Complete submission text file 0001193125-23-247446.txt   3553064

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bhc-20230929.xsd EX-101.SCH 2521
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20230929_lab.xml EX-101.LAB 17945
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20230929_pre.xml EX-101.PRE 11231
10 EXTRACTED XBRL INSTANCE DOCUMENT d490226d8k_htm.xml XML 3447
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 231296088
SIC: 2834 Pharmaceutical Preparations